Primum non nocere: Allo-HSCT for AML in CR1 Editorial
| Authors: | Shouval, R.; Soiffer, R. J. |
| Title: | Primum non nocere: Allo-HSCT for AML in CR1 |
| Abstract: | In this issue of Blood, Fenwarth et al demonstrate the potential applicability of a knowledge bank (KB) to inform decision making as to whether patients ages 18 to 59 years with acute myeloid leukemia (AML) should undergo allogeneic hematopoietic stem cell transplantation (HSCT) in first complete remission (CR1) or whether it should be deferred to a later stage. © 2021 by The American Society of Hematology. |
| Journal Title: | Blood |
| Volume: | 137 |
| Issue: | 4 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-01-28 |
| Start Page: | 438 |
| End Page: | 439 |
| Language: | English |
| DOI: | 10.1182/blood.2020008641 |
| PUBMED: | 33507303 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 March 2021 -- Source: Scopus |
